CKD impairs bone metabolism and leads to CKD-MBD by reducing kidney function and disturbing the normal physiological mechanisms that regulate the blood levels of vitamin D, phosphate, calcium, PTH, and FGF23 [4–6]. The gene discussed is FGF23; the disease is Marchiafava-Bignami disease.